WO2007150075A3 - Compositions comprising nanoparticulate meloxicam and controlled release hydrocodone - Google Patents
Compositions comprising nanoparticulate meloxicam and controlled release hydrocodone Download PDFInfo
- Publication number
- WO2007150075A3 WO2007150075A3 PCT/US2007/072054 US2007072054W WO2007150075A3 WO 2007150075 A3 WO2007150075 A3 WO 2007150075A3 US 2007072054 W US2007072054 W US 2007072054W WO 2007150075 A3 WO2007150075 A3 WO 2007150075A3
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- hydrocodone
- compositions
- composition
- component
- controlled release
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/47—Quinolines; Isoquinolines
- A61K31/485—Morphinan derivatives, e.g. morphine, codeine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/141—Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers
- A61K9/145—Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers with organic compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/141—Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers
- A61K9/146—Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers with organic macromolecular compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
- A61K9/5073—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals having two or more different coatings optionally including drug-containing subcoatings
- A61K9/5078—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals having two or more different coatings optionally including drug-containing subcoatings with drug-free core
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
- A61K9/5084—Mixtures of one or more drugs in different galenical forms, at least one of which being granules, microcapsules or (coated) microparticles according to A61K9/16 or A61K9/50, e.g. for obtaining a specific release pattern or for combining different drugs
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
- A61K9/51—Nanocapsules; Nanoparticles
- A61K9/5107—Excipients; Inactive ingredients
- A61K9/513—Organic macromolecular compounds; Dendrimers
- A61K9/5138—Organic macromolecular compounds; Dendrimers obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone, poly(meth)acrylates
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
- A61K9/51—Nanocapsules; Nanoparticles
- A61K9/5107—Excipients; Inactive ingredients
- A61K9/513—Organic macromolecular compounds; Dendrimers
- A61K9/5161—Polysaccharides, e.g. alginate, chitosan, cellulose derivatives; Cyclodextrin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/04—Centrally acting analgesics, e.g. opioids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
- A61P29/02—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID] without antiinflammatory effect
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/10—Dispersions; Emulsions
- A61K9/107—Emulsions ; Emulsion preconcentrates; Micelles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
- A61K9/5005—Wall or coating material
- A61K9/5021—Organic macromolecular compounds
- A61K9/5026—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone, poly(meth)acrylates
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B82—NANOTECHNOLOGY
- B82Y—SPECIFIC USES OR APPLICATIONS OF NANOSTRUCTURES; MEASUREMENT OR ANALYSIS OF NANOSTRUCTURES; MANUFACTURE OR TREATMENT OF NANOSTRUCTURES
- B82Y5/00—Nanobiotechnology or nanomedicine, e.g. protein engineering or drug delivery
Abstract
Priority Applications (7)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
MX2008016115A MX2008016115A (en) | 2006-06-23 | 2007-06-25 | Compositions comprising nanoparticulate meloxicam and controlled release hydrocodone. |
EP07784540A EP2032139A4 (en) | 2006-06-23 | 2007-06-25 | Compositions comprising nanoparticulate meloxicam and controlled release hydrocodone |
AU2007260822A AU2007260822B2 (en) | 2006-06-23 | 2007-06-25 | Compositions comprising nanoparticulate meloxicam and controlled release hydrocodone |
CA002660650A CA2660650A1 (en) | 2006-06-23 | 2007-06-25 | Compositions comprising nanoparticulate meloxicam and controlled release hydrocodone |
JP2009516757A JP2009541360A (en) | 2006-06-23 | 2007-06-25 | Composition comprising nanoparticulate meloxicam and controlled release hydrocodone |
IL196066A IL196066A0 (en) | 2006-06-23 | 2008-12-18 | Compositions comprising nanoparticulate meloxicam and controlled release hydrocodone |
NO20090119A NO20090119L (en) | 2006-06-23 | 2009-01-09 | Composition comprising controlled release nanoparticulated meloxicam and hydrocodone |
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US81588406P | 2006-06-23 | 2006-06-23 | |
US60/815,884 | 2006-06-23 |
Publications (2)
Publication Number | Publication Date |
---|---|
WO2007150075A2 WO2007150075A2 (en) | 2007-12-27 |
WO2007150075A3 true WO2007150075A3 (en) | 2008-04-24 |
Family
ID=38834447
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/US2007/072054 WO2007150075A2 (en) | 2006-06-23 | 2007-06-25 | Compositions comprising nanoparticulate meloxicam and controlled release hydrocodone |
Country Status (11)
Country | Link |
---|---|
EP (1) | EP2032139A4 (en) |
JP (1) | JP2009541360A (en) |
KR (1) | KR20090023729A (en) |
CN (1) | CN101484169A (en) |
AU (1) | AU2007260822B2 (en) |
CA (1) | CA2660650A1 (en) |
IL (1) | IL196066A0 (en) |
MX (1) | MX2008016115A (en) |
NO (1) | NO20090119L (en) |
WO (1) | WO2007150075A2 (en) |
ZA (1) | ZA200810098B (en) |
Cited By (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US8808740B2 (en) | 2010-12-22 | 2014-08-19 | Purdue Pharma L.P. | Encased tamper resistant controlled release dosage forms |
US9149533B2 (en) | 2013-02-05 | 2015-10-06 | Purdue Pharma L.P. | Tamper resistant pharmaceutical formulations |
US9522135B2 (en) | 2009-04-24 | 2016-12-20 | Iceutica Pty Ltd. | Formulation of indomethacin |
Families Citing this family (18)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20040234602A1 (en) | 2001-09-21 | 2004-11-25 | Gina Fischer | Polymer release system |
US20040253310A1 (en) | 2001-09-21 | 2004-12-16 | Gina Fischer | Morphine polymer release system |
ES2360102T3 (en) | 2003-03-26 | 2011-05-31 | Egalet A/S | SYSTEM FOR CONTROLLED RELEASE OF MORPHINE. |
AU2008258596B2 (en) | 2007-06-04 | 2013-02-14 | Egalet Ltd | Controlled release pharmaceutical compositions for prolonged effect |
US20090311335A1 (en) * | 2008-06-12 | 2009-12-17 | Scott Jenkins | Combination of a triptan and an nsaid |
NZ594207A (en) | 2009-02-06 | 2013-03-28 | Egalet Ltd | Immediate release composition resistant to abuse by intake of alcohol |
JP6072539B2 (en) | 2009-05-27 | 2017-02-01 | アルカーメス ファーマ アイルランド リミテッド | Reduction of flaky aggregation in nanoparticulate active agent compositions |
EP2445487A2 (en) | 2009-06-24 | 2012-05-02 | Egalet Ltd. | Controlled release formulations |
CA2822769C (en) | 2010-12-23 | 2016-10-04 | Purdue Pharma L.P. | Tamper resistant solid oral dosage forms |
EP2586429A1 (en) * | 2011-10-26 | 2013-05-01 | Freund Pharmatec Ltd. | Multi-unit drug delivery device for pulsatile or sustained release |
CN103070906A (en) * | 2011-12-08 | 2013-05-01 | 赵联华 | Quality control method of injection composition for treating orthopedic diseases |
JP5902318B2 (en) * | 2011-12-29 | 2016-04-13 | ラボラトリオス アンドロマコ ソシエダッド アノニマ | Vaginal ring containing meloxicam and an agent that regulates the release of active ingredient and can be used for continuous use contraception in women |
EP2877161A1 (en) | 2012-07-06 | 2015-06-03 | Egalet Ltd. | Abuse deterrent pharmaceutical compositions for controlled release |
US10751287B2 (en) | 2013-03-15 | 2020-08-25 | Purdue Pharma L.P. | Tamper resistant pharmaceutical formulations |
US9526734B2 (en) | 2014-06-09 | 2016-12-27 | Iceutica Pty Ltd. | Formulation of meloxicam |
US9132096B1 (en) | 2014-09-12 | 2015-09-15 | Alkermes Pharma Ireland Limited | Abuse resistant pharmaceutical compositions |
WO2021257784A1 (en) * | 2020-06-18 | 2021-12-23 | Verté Therapeutics, Llc | Injectable meloxicam formulations |
CN115025066B (en) * | 2021-05-25 | 2023-05-16 | 重庆市畜牧科学院 | Preparation method of traditional Chinese medicine slow-release particles with stable quality and capable of resisting diarrhea of piglets |
Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20040176402A1 (en) * | 2000-02-08 | 2004-09-09 | Benjamin Oshlack | Controlled-release compositions containing opioid agonist and antagonist |
US20040229038A1 (en) * | 2003-03-03 | 2004-11-18 | Elan Pharma International Ltd. | Nanoparticulate meloxicam formulations |
US20040266807A1 (en) * | 1999-10-29 | 2004-12-30 | Euro-Celtique, S.A. | Controlled release hydrocodone formulations |
Family Cites Families (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
RS49982B (en) * | 1997-09-17 | 2008-09-29 | Euro-Celtique S.A., | Synergistic analgesic combination of opioid analgesic and cyclooxygenase-2 inhibitor |
JP4613275B2 (en) * | 1998-11-02 | 2011-01-12 | エラン ファーマ インターナショナル,リミティド | Multiparticulate modified release composition |
JP2005508939A (en) * | 2001-10-12 | 2005-04-07 | エラン ファーマ インターナショナル,リミティド | Composition having combined immediate release and sustained release characteristics |
-
2007
- 2007-06-25 CA CA002660650A patent/CA2660650A1/en not_active Abandoned
- 2007-06-25 EP EP07784540A patent/EP2032139A4/en not_active Withdrawn
- 2007-06-25 WO PCT/US2007/072054 patent/WO2007150075A2/en active Application Filing
- 2007-06-25 KR KR1020097001440A patent/KR20090023729A/en not_active Application Discontinuation
- 2007-06-25 JP JP2009516757A patent/JP2009541360A/en active Pending
- 2007-06-25 CN CNA2007800235166A patent/CN101484169A/en active Pending
- 2007-06-25 AU AU2007260822A patent/AU2007260822B2/en not_active Expired - Fee Related
- 2007-06-25 MX MX2008016115A patent/MX2008016115A/en not_active Application Discontinuation
-
2008
- 2008-11-27 ZA ZA200810098A patent/ZA200810098B/en unknown
- 2008-12-18 IL IL196066A patent/IL196066A0/en unknown
-
2009
- 2009-01-09 NO NO20090119A patent/NO20090119L/en not_active Application Discontinuation
Patent Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20040266807A1 (en) * | 1999-10-29 | 2004-12-30 | Euro-Celtique, S.A. | Controlled release hydrocodone formulations |
US20040176402A1 (en) * | 2000-02-08 | 2004-09-09 | Benjamin Oshlack | Controlled-release compositions containing opioid agonist and antagonist |
US20040229038A1 (en) * | 2003-03-03 | 2004-11-18 | Elan Pharma International Ltd. | Nanoparticulate meloxicam formulations |
Cited By (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US9522135B2 (en) | 2009-04-24 | 2016-12-20 | Iceutica Pty Ltd. | Formulation of indomethacin |
US8808740B2 (en) | 2010-12-22 | 2014-08-19 | Purdue Pharma L.P. | Encased tamper resistant controlled release dosage forms |
US9393206B2 (en) | 2010-12-22 | 2016-07-19 | Purdue Pharma L.P. | Encased tamper resistant controlled release dosage forms |
US9572779B2 (en) | 2010-12-22 | 2017-02-21 | Purdue Pharma L.P. | Encased tamper resistant controlled release dosage forms |
US9149533B2 (en) | 2013-02-05 | 2015-10-06 | Purdue Pharma L.P. | Tamper resistant pharmaceutical formulations |
US9579389B2 (en) | 2013-02-05 | 2017-02-28 | Purdue Pharma L.P. | Methods of preparing tamper resistant pharmaceutical formulations |
Also Published As
Publication number | Publication date |
---|---|
AU2007260822A1 (en) | 2007-12-27 |
CN101484169A (en) | 2009-07-15 |
MX2008016115A (en) | 2009-01-20 |
EP2032139A2 (en) | 2009-03-11 |
AU2007260822B2 (en) | 2012-07-05 |
EP2032139A4 (en) | 2012-08-22 |
NO20090119L (en) | 2009-03-20 |
ZA200810098B (en) | 2009-12-30 |
KR20090023729A (en) | 2009-03-05 |
IL196066A0 (en) | 2009-09-01 |
WO2007150075A2 (en) | 2007-12-27 |
CA2660650A1 (en) | 2007-12-27 |
JP2009541360A (en) | 2009-11-26 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
WO2007150075A3 (en) | Compositions comprising nanoparticulate meloxicam and controlled release hydrocodone | |
WO2007150074A3 (en) | Compositions comprising nanoparticulate naproxen and controlled release hydrocodone | |
WO2006102610A3 (en) | Bicycloheteroaryl compounds as p2x7 modulators and uses thereof | |
WO2007109192A3 (en) | Bicycloheteroaryl compounds as p2x7 modulators and uses thereof | |
WO2007109160A3 (en) | Bicycloheteroaryl compounds as p2x7 modulators and uses thereof | |
WO2007109154A3 (en) | Bicycloheteroaryl compounds as p2x7 modulators and uses thereof | |
WO2010003127A3 (en) | Antagonists of prostaglandin d2 receptors | |
WO2007019439A3 (en) | Block copolymer compositions and uses thereof | |
WO2009145989A3 (en) | Aminoalkylphenyl antagonists of prostaglandin d2 receptors | |
WO2007109182A3 (en) | Bicycloheteroaryl compounds as p2x7 modulators and uses thereof | |
WO2006002365A3 (en) | Microparticles with high loadings of a bioactive agent | |
WO2006124047A3 (en) | Pharmaceutical formulations containing microparticles or nanoparticles of a delivery agent | |
WO2009087634A3 (en) | Methods and compositions for oral administration of insulin | |
WO2007109201A3 (en) | Bicycloheteroaryl compounds as p2x7 modulators and uses thereof | |
WO2008033351A3 (en) | Multimodal abuse resistant and extended release formulations | |
EP2045251A4 (en) | Compound that can inhibit ubc13-uev interactions, pharmaceutical compositions and therapeutic uses | |
WO2007042271A3 (en) | Nutraceutical composition for the treatment of muscle wasting | |
WO2006131591A3 (en) | An entacapone-containing oral dosage form | |
IL195488A (en) | Compounds, pharmaceutical compositions comprising the same and uses thereof | |
WO2006099514A3 (en) | Drug delivery compositions and related methods | |
WO2010019239A3 (en) | Pharmaceutical composition of n- [2,4-bis (1, 1 -dimethylethyl) - 5 - hydroxyphenyl] - 1, 4 - dihydro - 4 - oxoquinoline - 3 - carboxamide and administration thereof | |
WO2009121039A3 (en) | Administration of benzodiazepine compositions | |
IL183357A0 (en) | Oral medicament for the modified release of at least one active principle, in multimicrocapsule form | |
IL196426A (en) | Microparticles based on an amphiphilic copolymer, processes for the preparation thereof and pharmaceutical compositions containing the same | |
WO2010042652A3 (en) | Heteroalkyl biphenyl antagonists of prostaglandin d2 receptors |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
WWE | Wipo information: entry into national phase |
Ref document number: 200780023516.6 Country of ref document: CN |
|
121 | Ep: the epo has been informed by wipo that ep was designated in this application |
Ref document number: 07784540 Country of ref document: EP Kind code of ref document: A2 |
|
WWE | Wipo information: entry into national phase |
Ref document number: 2007260822 Country of ref document: AU |
|
WWE | Wipo information: entry into national phase |
Ref document number: 2660650 Country of ref document: CA |
|
WWE | Wipo information: entry into national phase |
Ref document number: 2007784540 Country of ref document: EP |
|
WWE | Wipo information: entry into national phase |
Ref document number: MX/A/2008/016115 Country of ref document: MX |
|
WWE | Wipo information: entry into national phase |
Ref document number: 196066 Country of ref document: IL |
|
WWE | Wipo information: entry into national phase |
Ref document number: 2009516757 Country of ref document: JP |
|
NENP | Non-entry into the national phase |
Ref country code: DE |
|
ENP | Entry into the national phase |
Ref document number: 2007260822 Country of ref document: AU Date of ref document: 20070625 Kind code of ref document: A |
|
WWE | Wipo information: entry into national phase |
Ref document number: 1020097001440 Country of ref document: KR |
|
NENP | Non-entry into the national phase |
Ref country code: RU |
|
ENPW | Started to enter national phase and was withdrawn or failed for other reasons |
Ref document number: PI0713038 Country of ref document: BR Free format text: RETIRADO O PEDIDO POR NAO CUMPRIMENTO DA EXIGENCIA DA RPI 2149 DE 13/03/2012. |